The OR for hyperuricaemia according to different status of parameters of women in different age groups (Group Ⅰ–Ⅲ)
| Group I (18–29 years old) | Group II (30–39 years old) | Group III (40–49 years old) | ||||
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| BMI (kg/m2) | ||||||
| 18.5≤BMI<24.0 (Ref.) | ||||||
| BMI <18.5 | 0.415 (0.122 to 1.411) | 0.159 | 0.920 (0.375 to 2.260) | 0.856 | 1.093 (0.251 to 4.765) | 0.905 |
| 24.0≤BMI<28.0 | 4.061 (2.101 to 7.849) | <0.001 | 3.237 (2.074 to 5.054) | <0.001 | 2.241 (1.448 to 3.469) | <0.001 |
| BMI≥28.0 | 9.477 (4.180 to 21.486) | <0.001 | 4.891 (2.673 to 8.951) | <0.001 | 3.037 (1.638 to 5.632) | <0.001 |
| Blood pressure (mm Hg) | ||||||
| Normotensive (Ref.) | ||||||
| Pre-HT | 1.487 (0.823 to 2.684) | 0.188 | 1.189 (0.774 to 1.827) | 0.430 | 0.974 (0.623 to 1.521) | 0.907 |
| Grade1 HT | 1.701 (0.498 to 5.811) | 0.397 | 1.694 (0.782 to 3.668) | 0.181 | 1.582 (0.882 to 2.837) | 0.124 |
| Grade 2/3 HT | 13.906 (0.761 to 254.245) | 0.076 | 5.733 (1.736 to 18.938) | 0.004 | 2.062 (0.881 to 4.823) | 0.095 |
| FPG (mmol/L) | ||||||
| FPG <6.1 (Ref.) | ||||||
| 6.1≤FPG<7.0 | 5.191 (0.141 to 191.013) | 0.371 | 5.827 (2.052 to 16.549) | 0.001 | 1.062 (0.379 to 2.970) | 0.909 |
| FPG≥7.0 | – | – | 1.598 (0.426 to 5.991) | 0.487 | 0.637 (0.172 to 2.364) | 0.500 |
| Cholesterol (mmol/L) | ||||||
| TC ≤6.22 (Ref.) | ||||||
| TC >6.22 | 5.220 (0.311 to 87.682) | 0.251 | 0.434 (0.101 to 1.869) | 0.263 | 1.388 (0.504 to 3.824) | 0.526 |
| Triglyceride (mmol/L) | ||||||
| TG ≤2.26 (Ref.) | ||||||
| TG >2.26 | 6.720 (2.131 to 21.191) | 0.001 | 3.534 (1.904 to 6.562) | <0.001 | 1.381 (0.765 to 2.495) | 0.284 |
| HDL-C (mmol/L) | ||||||
| HDL-C ≥1.04 (Ref.) | ||||||
| HDL-C <1.04 | 1.841 (0.709 to 4.780) | 0.210 | 2.172 (1.230 to 3.834) | 0.007 | 3.937 (2.348 to 6.601) | <0.001 |
| LDL-C (mmol/L) | ||||||
| LDL-C ≤4.14 (Ref.) | ||||||
| LDL-C >4.14 | – | – | 2.265 (0.762 to 6.735) | 0.142 | 1.608 (0.599 to 4.317) | 0.346 |
| eGFR (mL/(min*1.73 m2)) | ||||||
| eGFR ≥90 (Ref.) | ||||||
| 60≤eGFR≤89 | 1.698 (0.883 to 3.265) | 0.112 | 2.097 (1.392 to 3.158) | <0.001 | 2.057 (1.374 to 3.079) | <0.001 |
| eGFR ≤59 | – | – | 25.866 (3.719 to 179.914) | 0.001 | 18.045 (5.201 to 62.602) | <0.001 |
| Albuminuria | ||||||
| ± (Ref.) | ||||||
| + | – | – | – | – | 2.020 (0.254 to 16.078) | 0.506 |
| ++ | – | – | 4.558 (0.463 to 44.879) | 0.194 | 1.118 (0.169 to 7.400) | 0.908 |
| +++ | – | – | 0.679 (0.029 to 15.939) | 0.810 | 6.224 (0.654 to 59.223) | 0.112 |
| Urinary pH | ||||||
| 6≤pH≤7 (Ref.) | ||||||
| pH <6 | 1.392 (0.777 to 2.495) | 0.266 | 2.099 (1.352 to 3.258) | 0.001 | 2.308 (1.530 to 3.482) | <0.001 |
| pH >7 | 0.235 (0.030 to 1.858) | 0.170 | 1.191 (0.492 to 2.882) | 0.698 | 0.374 (0.089 to 1.566) | 0.178 |
| Nephrolithiasis | ||||||
| No (Ref.) | ||||||
| Yes | 1.115 (0.419 to 2.962) | 0.828 | 1.001 (0.533 to 1.880) | 0.998 | 1.206 (0.690 to 2.108) | 0.510 |
Blood pressure (mm Hg): normotensive: SBP <120 and DBP<80; pre-HT: SBP of 120–139 and/or DBP of 80–89; Grade 1 HT: SBP of 140–159 and/or DBP of 90–99; Grade 2/3 HT: SBP ≥160 and/or DBP≥100.
BMI, body mass index; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TC, total cholesterol; TG, triglyceride.